About Freydis Pharmaceuticals LLP
Data last updated:
Freydis Pharmaceuticals LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 24 February 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAW-0226. Its GSTIN is 27AAHFF6215H1ZH (Maharashtra).
The LLP has a total obligation of contribution of ₹60,000. It is led by designated partners Lata Shukla and Pooja Devi.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at 104 D Bhoomi Valley Thakur Village Next To N.G.Suncity Kandivali East, Mumbai, Maharashtra, India – 400101.
For more details, the LLP can be reached via its website freydispharma.com.
Company details
Contact details
Freydis Pharmaceuticals LLP's registered office is in Mumbai, Maharashtra.
- Registered Address104 D Bhoomi Valley Thakur Village Next To N.G.Suncity Kandivali East, Mumbai, Maharashtra, India – 400101
- IndustryChemicals, Manufacturing, Chemicals And Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Freydis Pharmaceuticals LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Freydis Pharmaceuticals LLP, buy the company report.
Designated partners of Freydis Pharmaceuticals LLP
Freydis Pharmaceuticals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lata Shukla Also directs: Freydis Medicare LLP, Aim Medicare LLP | Designated Partner | 01 Jan 2023 | 3 Years 10 Months | Current |
| Pooja Devi Also directs: Freydis Medicare LLP | Designated Partner | 24 Feb 2021 | 5 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Freydis Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Freydis Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Freydis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHFF6215H1ZH | Maharashtra | Active | 24 Mar 2021 |
To see the full GST registrations and return filing status of Freydis Pharmaceuticals LLP, buy the company report.
Recent activity
Freydis Pharmaceuticals LLP has 3 designated partner changes on record since 2021: 2 appointments and 1 cessation. The latest: Anjali Malan ceased to be Designated Partner on 01 Jan 2023.
Frequently asked questions
Freydis Pharmaceuticals is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in manufacturing, within the chemicals industry. It was incorporated on 24 February 2021 (5+ years old) and is registered under LLPIN AAW-0226.
Freydis Pharmaceuticals has 2 current designated partners:
- Lata Shukla - Designated Partner
- Pooja Devi - Designated Partner
The latest financial statements of Freydis Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Freydis Pharmaceuticals is 27AAHFF6215H1ZH, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Freydis Pharmaceuticals is AAW-0226. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Freydis Pharmaceuticals was incorporated on 24 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Anjali Malan ceased to be Designated Partner on 01 Jan 2023. Lata Shukla was appointed as Designated Partner on 01 Jan 2023. Pooja Devi was appointed as Designated Partner on 24 Feb 2021.
Freydis Pharmaceuticals can be reached through the website freydispharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Freydis Pharmaceuticals is at 104 D Bhoomi Valley Thakur Village Next To N.G.Suncity Kandivali East, Mumbai, Maharashtra, India – 400101.
Freydis Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
